Kathryn J. Chavez, Ph.D. - Publications
Affiliations: | 2008 | Cornell University, Ithaca, NY, United States |
Area:
Biochemistry, Molecular Biology, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2016 | Dine JL, O'Sullivan CC, Voeller D, Greer YE, Chavez KJ, Conway CM, Sinclair S, Stone B, Amiri-Kordestani L, Merchant AS, Hewitt SM, Steinberg SM, Swain SM, Lipkowitz S. The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. Breast Cancer Research and Treatment. 155: 235-51. PMID 26759246 DOI: 10.1007/s10549-015-3673-z | 0.555 | |||
2010 | Chavez KJ, Garimella SV, Lipkowitz S. Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. Breast Disease. 32: 35-48. PMID 21778573 DOI: 10.3233/BD-2010-0307 | 0.552 | |||
Show low-probability matches. |